Amicus’ oral Fabry disease drug approved in USDecision follows approval in Europe Share XAmicus’ oral Fabry disease drug approved in UShttps://pharmaphorum.com/news/amicus-oral-fabry-disease-drug-approved/
Amicus to file Fabry drug after FDA changes mindRegulator drops demand for further phase 3 trial. Share XAmicus to file Fabry drug after FDA changes mindhttps://pharmaphorum.com/news/amicus-therapeutics-fabry-drug-us-fda-changes-mind/
Amicus set for share of Fabry market after NICE approvalEngland and Wales’ cost effectiveness watchdog NICE has given a final recommendation to a new treatment for the Share XAmicus set for share of Fabry market after NICE approvalhttps://pharmaphorum.com/news/amicus-set-share-fabry-market-nice-approval/